N. Purvis

A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

P. Sonneveld, P. Sonneveld, J. Verweij, 2004, Cancer Chemotherapy and Pharmacology.

Single-Cell Network Profiling (SCNP)-Based Classifier to Predict Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia (AML): Validation in Two Independent Sample Sets from ECOG and SWOG Trials

J. Radich, D. Spellmeyer, F. Appelbaum, 2012 .

Development and validation of a single‐cell network profiling assay‐based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group

S. Meshinchi, T. Alonzo, R. Gerbing, 2013, British journal of haematology.

Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia

D. Rossi, G. Gaidano, G. Pizzolo, 2017, Haematologica.

Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part III – analytical issues

A. Porwit, T. Shankey, Shabnam Tangri, 2013, Cytometry. Part B, Clinical cytometry.

Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia

J. Radich, D. Spellmeyer, F. Appelbaum, 2015, PloS one.